Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zenithhealthcare.com | |
Market Cap | 33.86 Cr. | |
Enterprise Value(EV) | 31.32 Cr. | 2021-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.07 | Trailing Twelve Months Ending 2021-12 |
Price-Earning Ratio (PE) | 88.40 | Trailing Twelve Months Ending 2021-12 |
Industry PE | 29.26 | Trailing Twelve Months Ending 2021-12 |
Book Value / Share | 1.37 | Trailing Twelve Months Ending 2021-12 |
Price to Book Value | 4.60 | Calculated using Price: 6.30 |
Dividend Yield | 0.00 | Period Ending 2021-03 |
No. of Shares Subscribed | 5.37 Cr. | 53,739,000 Shares |
FaceValue | 1 | |
Company Profile | ||
Zenith Healthcare was incorporated in the year 1994. The company has its registered and corporate office located at Ahmedabad, Gujarat. The company has its manufacturing facilities located at Changodar, Gujarat and has installed capacity to manufacture 168 million tablets, 37.5 million capsules and 90 million liquids. Business area of the company:- Zenith Healthcare is engaged in the manufacturing of tablets, capsules, ointments, and liquid injectable among others. |
1 Day |
|
-3.83% |
1 Week |
|
-1.88% |
1 Month |
|
-12.17% |
3 Month |
|
-18.44% |
6 Month |
|
-8.85% |
1 Year |
|
-24.15% |
2 Year |
|
+528.00% |
5 Year |
|
+503.85% |
10 Year |
|
+1131.37% |
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 0.14 | -4.37 | -4.06 | -5.45 | -2.78 | 4.95 | 2.38 | 9.27 | 6.64 | |
Return on Capital Employed (%) | 0.19 | -6.48 | -5.82 | -8.24 | -3.04 | 7.38 | 2.95 | 9.68 | 8.60 | |
Return on Assets (%) | 0.12 | -3.90 | -3.73 | -5.00 | -2.55 | 4.37 | 2.03 | 7.60 | 5.28 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-09* Rs. Cr. |
Shh. Funds | 6 | 6 | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 7 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | |
Minority Int. | |||||||||||
Equity & Liab. | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 10 | |
Non Curr. Assets | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Curr. Assets | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 8 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 10 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-12 Rs. Cr. TTM |
Net Sales | 4 | 3 | 4 | 3 | 5 | 10 | 10 | 12 | 14 | 16 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 4 | 3 | 4 | 4 | 5 | 10 | 10 | 12 | 14 | 17 | |
Total Expenditure | -4 | -4 | -4 | -4 | -5 | -9 | -10 | -11 | -13 | -16 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Exceptional Items | 0 | 0 | |||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | -1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | ||||||
Net Change | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 1 | -2 | |
Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 |
Fri, 20 May 2022
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday May 28 2022 ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve Zenith Healthcare Ltd. informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve the Audited Financial Results (Standalone) for the quarter and year ended on March 31 2022 and such other items as stated in notice. |
||||||||||||||||||||||||||||||||||||||
Sat, 14 May 2022
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: MIHIR S SHAH Designation: COMPANY SECRETARY EmailId: mahendrazenith@hotmail.com Name of the Chief Financial Officer: PRASHANT GUPTA Designation: CHIEF FINANCIAL OFFICER EmailId: mahendrazenith@hotmail.com Date: 14/05/2022 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
||||||||||||||||||||||||||||||||||||||
Sat, 16 Apr 2022
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Date: 16/04/2022 |
Fri, 20 May 2022 |
|
|
|
|
|